Zelira Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	0.01	0.59	0.15	2.75	4.97
Cash & Short-Term Investments	0.01	0.59	0.15	2.75	4.97
Cash Growth	-99.03%	300.91%	-94.68%	-44.75%	192.93%
Accounts Receivable	0	0.01	-0.01	0.1	0.04
Other Receivables	0.03	2.3	0.01	0.16	0.02
Receivables	0.03	2.31	-0	0.26	0.06
Inventory	0.48	1.25	1.53	1.96	0.87
Prepaid Expenses	0.1	0.11	0.1	0.12	0.19
Total Current Assets	0.61	4.26	1.77	5.08	6.09
Property, Plant & Equipment	0.12	0.23	0.52	0.85	1.24
Long-Term Investments	-	-	-	-	0.07
Goodwill	-	-	30.75	30.75	-
Other Intangible Assets	0.52	0.65	0.81	0.97	31.87
Other Long-Term Assets	0.04	0.04	0.04	0.06	0.1
Total Assets	1.3	5.18	33.89	37.7	39.37
Accounts Payable	3.45	3.41	1.74	1.51	0.98
Short-Term Debt	1.99	3.54	-	-	-
Current Portion of Leases	0.15	0.15	0.14	0.12	0.09
Total Current Liabilities	5.59	7.09	1.88	1.63	1.08
Long-Term Debt	-	2.11	-	-	-
Long-Term Leases	-	0.15	0.3	0.38	0.46
Total Liabilities	5.59	9.36	2.18	2.01	1.54
Common Stock	45.52	45.52	45.52	43.75	36.65
Retained Earnings	-84.96	-81.34	-44.77	-39.19	-27.25
Comprehensive Income & Other	34.98	31.31	31.05	30.65	28.43
Total Common Equity	-4.46	-4.51	31.8	35.2	37.83
Minority Interest	0.17	0.34	-0.09	0.49	-
Shareholders' Equity	-4.29	-4.17	31.71	35.69	37.83
Total Liabilities & Equity	1.3	5.18	33.89	37.7	39.37
Total Debt	2.14	5.95	0.44	0.5	0.55
Net Cash (Debt)	-2.14	-5.36	-0.29	2.25	4.42
Net Cash Growth	-	-	-	-49.20%	315.14%
Net Cash Per Share	-0.19	-0.47	-0.03	0.28	0.67
Filing Date Shares Outstanding	11.9	11.35	11.35	9.58	6.8
Total Common Shares Outstanding	11.9	11.35	11.35	9.58	6.8
Working Capital	-4.98	-2.83	-0.11	3.45	5.01
Book Value Per Share	-0.37	-0.40	2.80	3.68	5.56
Tangible Book Value	-4.98	-5.17	0.24	3.49	5.96
Tangible Book Value Per Share	-0.42	-0.46	0.02	0.36	0.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.